About US
Contact us
-
Strides Shasun to acquire Perrigo API IndiaIndian pharmaceutical company Strides Shasun has entered agreements to acquire complete shares in Perrigo API India for Rs1bn ($14.81m). Pursuant to the merger with Shasun Pharmaceutical in 2014, Str2016/12/22
-
EMA accepts Sanofi and Regeneron’s MAA for DupixentSanofi and Regeneron Pharmaceuticals’ marketing authorisation application (MAA) for Dupixent (dupilumab) has been accepted for review by the European Medicines Agency (EMA). Dupixent is being investi2016/12/21
-
AstraZeneca and Eli Lilly partner to co-develop Alzheimer’s disease treatmentUK-based AstraZeneca and Eli Lilly have signed an agreement to co-develop a new antibody selective for amyloid-beta 42 (Aβ42) for Alzheimer’s disease (AD) treatment, known as MEDI1814. At present, Aβ2016/12/21
-
UK’s CRT Pioneer Fund to invest in new blood cancer drugsUK’s Cancer Research Technology (CRT) Pioneer Fund has announced an investment to develop a new class of drugs for blood cancer, which will target a protein called B-cell lymphoma 6 (BCL6). Scientist2016/12/20
-
Bristol-Myers Squibb's Opdivo approved to treat blood cancer in EUBristol-Myers Squibb's drug Opdivo (nivolumab) has been approved for use in the European Union (EU) to treat classical Hodgkin lymphoma (cHL), a type of blood cancer. Hodgkin lymphoma is a cancer tha2016/12/20
-
New Myeloma Genome Project established to advance diagnosis and treatmentsCelgene, the Dana-Farber Cancer Institute and the University of Arkansas for Medical Sciences have collaboratively launched a new initiative known as the Myeloma Genome Project. The project is aimed2016/12/19
-
EIB to support Amryt Pharma’s new treatment for skin disordersThe European Investment Bank (EIB) will grant a €20m loan to support a new treatment being developed by Irish company Amryt Pharma for skin disorders. Epidermolysis Bullosa (EB) is a rare and inherit2016/12/19
-
UK scientists create map of licensed drugs to search for future treatmentsUK-based scientists at the Institute of Cancer Research (ICR) have created a map of all 1,578 licensed drugs and their mechanisms of action to identify ‘uncharted waters’ in the search for future trea2016/12/16
-
Cancer Research UK to invest £226m in cancer researchCancer Research UK has announced an investment of £190m in 13 centres over the next five years. Additionally, £36m will be invested by Cancer Research and the Departments of Health over f2016/12/16
-
NICE recommends GSK's new injectable asthma drug NucalaUK’s National Institute for Health and Care Excellence (NICE) has recommended GlaxoSmithKline's (GSK) new injectable asthma drug Nucala (Mepolizumab) for use in the country’s state-run health service2016/12/15